Molecular Imaging

AuntMinnieEurope.com Molecular Imaging Insider

By Philip Ward

PET/CT continues to make giant strides in the management of prostate cancer. Radiologists and medical physicists from a top Irish hospital have shared their latest experiences in this area.

April 24, 2025

F-18 PSMA PET-CT proves clinical value in prostate cancer

By Philip Ward

F-18 prostate-specific membrane antigen (PSMA) PET/CT is having a major impact on patient care and therapy decisions in prostate cancer, but it’s crucial to bear in mind the modality’s diagnostic quirks.

April 24, 2025

Combined PET scans predict progression of Alzheimer’s

By Will Morton

Combining information from amyloid PET and FDG-PET scans can predict progression from mild cognitive impairment to Alzheimer's disease, a Spanish study has found.

April 23, 2025

PET scans predict outcomes for patients undergoing CAR T-cell therapy

By Will Morton

PET scans performed at one or three months after patients with large B-cell lymphoma begin CAR T-cell therapy can indicate whether they are responding to the treatment.

April 21, 2025

PET reveals brain’s responses to music

By Will Morton

PET has provided the first neuroimaging evidence that music affects the brain’s opioid receptor system.

April 9, 2025

SPECT/CT measure validated for diagnosing ATTR

By Will Morton

A research team in Finland has validated the accuracy of a SPECT/CT measure for diagnosing transthyretin amyloidosis.

April 7, 2025

Germans propose novel method for diagnosing Alzheimer’s

By Will Morton

Researchers in Cologne have put forward a fresh approach derived from brain PET imaging for diagnosing and staging Alzheimer’s disease.

March 31, 2025

EANM unveils plans for two new journals

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine (EANM) is launching two new journals of its own, following the end of its partnership with Springer Nature and the EJNMMI journals collection.

March 11, 2025

Novel PET method shows promise in low-grade breast cancer

By Will Morton

Dutch researchers have found that F-18 fluoroestradiol PET can improve staging of grade 1 or 2 estrogen receptor-positive breast cancer compared with F-18 FDG-PET.

March 10, 2025

PET/CT reveals new infections in ICU patients

By Will Morton

F-18 FDG-PET/CT is a valuable approach for diagnosing unknown infections in intensive care unit (ICU) patients.

February 25, 2025

PET advances in neurodegenerative disorders

By Philip Ward

PET imaging biomarkers have become central to diagnosing cases of dementia and Parkinson's disease, but it's vital to keep in mind pitfalls and artifacts.

February 13, 2025

Radiomics shows value in predicting prostate cancer survival

By Edna Astbury-Ward, PhD

Analysis indicates many radiomic features have prognostic value in prostate cancer, but they do not always improve the accuracy of survival prediction.

February 13, 2025

Page 1 of 119

Next Page